 "Strides Arcolab Q1 net profit at Rs 32 cr")
The company had posted a net loss of Rs 28.15 crore in the same period of previous year.
Net sales of the company rose to Rs 161.34 crore for the first quarter, as against Rs 120.42 crore in the same period of last year, Strides Arcolab said in a statement.
Also Read
The company follows January-December fiscal.
Commenting on the results, Strides Arcolab Group CEO and Vice Chairman Arun Kumar said: "Year 2013 has started on a promising note and we continue to be upbeat about our pharma business which is currently tracking ahead of guidance."
The Bangalore-based firm said its pharma revenues grew by 47 per cent to Rs 235 crore on a consolidated basis in first quarter, as against Rs 160 crore in the same period of 2012.
Shares of Strides Arcolab were trading at Rs 830.50on the BSE in late afternoon trade, up 1.12 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%